Eli Lilly to use GLP-1 windfall to fund M&A and diversify pipeline

Jacob Van Naarden is busy.  In addition to running Eli Lilly‘s oncology business, he’s now responsible for finding the drugmaker’s next opportunities as head of business development. And Lilly, now the world’s largest pharmaceutical company, is hungrier than ever for deals.  “The company’s financial strength right now, driven mostly by the weight loss business, is…

Read More

The end of Trump’s ‘weaponization’ fund is another sign Republicans are fighting back

The justice department on Monday said it was temporarily suspending the compensation scheme, citing the court decision. But critics, including some Republicans, demanded the administration go further and make clear it was giving up on the idea altogether. Blanche finally pulled the plug on Tuesday, telling House lawmakers: “We’re not moving forward with the fund.”…

Read More